Prostate Cancer And Agent Orange Is Not The Only Military Concern

Agent Orange is usually the first thing veterans with prostate cancer ask about.   Indeed, way back in 1998, Malecare was an early advocate for men exposed to Agent Orange. Military veterans as well as Vietnamese, Cambodian and Laotian civilians were exposed to Agent Orange, and many of those who are men are now diagnosed, [...]

By |2018-05-27T23:55:25-04:00May 25th, 2018|Advanced Prostate Cancer, Advocacy, Research|3 Comments

Latest PSA Screening Test Guidelines from USPSTF

Here is the latest challenge to PSA test usefulness for Prostate Cancer screening in the USA.  Malecare feels you should be empowered to participate in this national health policy issue.   The U.S. Preventive Services Task Force released a new guideline, determining that the potential benefits and harms of prostate-specific antigen (PSA)-based screening in men [...]

By |2020-02-04T12:09:46-05:00April 11th, 2017|Advocacy|0 Comments

For Our USA Readers: Office of Men’s Health Petition and Update

Our best chance for establishing an Office of Men's Health in the USA is now, in the early days of this new administration. Our Petition at whitehouse.gov is a first and important step.   Please sign and spread the word.  This effort is entirely up to us.  We can do this! Click and Sign here: [...]

Being A “Cancer Hater” is Not Productive

My wife Wendy periodically receives Facebook requests for her to “Hate Cancer.” Yes, she does hate cancer, but she wants us all to actually be productive about what we do with our “hate.” Wendy wrote on Facebook,  "I'm not a cut and paster, and certainly not a "hater," so I have an alternative suggestion.  I just had the [...]

By |2016-12-30T12:56:24-05:00December 30th, 2016|Advanced Prostate Cancer, Advocacy, Uncategorized|0 Comments

In the 1990’s USA: PSA Screening Reduced Instances of Initial Diagnosis of Metastatic Prostate Cancer By 50%

Screening for early cancer detection may reduce the rate of related metastatic disease, but not always. In a published study in the New England Journal of Medicine, researchers evaluated the incidence of men having a diagnosis of advanced, metastatic prostate cancer at the initial prostate cancer diagnosis. The researchers data from the Surveillance, Epidemiology, and [...]

Go to Top